Eschneider (Talk | contribs) |
Eschneider (Talk | contribs) |
||
Line 58: | Line 58: | ||
<div class="title">Accumulation Results</div> | <div class="title">Accumulation Results</div> | ||
− | To test whether our accumulation system with the importers <i>oprC</i>, <i>hmtA</i>, <i>copC</i> and <i>copD</i> works as expected, we conducted experiments indicating Cu(II) ion uptake. We conducted growth experiments as due to its toxicity intracellular copper hinders cell growth and this would point to a working uptake system. We also conducted membrane permeability assays to show the location in the outer membrane and the channel nature of the proteins. | + | <article>To test whether our accumulation system with the importers <i>oprC</i>, <i>hmtA</i>, <i>copC</i> and <i>copD</i> works as expected, we conducted experiments indicating Cu(II) ion uptake. We conducted growth experiments as due to its toxicity intracellular copper hinders cell growth and this would point to a working uptake system. We also conducted membrane permeability assays to show the location in the outer membrane and the channel nature of the proteins.</article> |
<h2>Toxicity assay</h2> | <h2>Toxicity assay</h2> |
Revision as of 17:51, 17 October 2018
Accumulation Results
Toxicity assay
Biobrick number | Components | Function |
---|---|---|
BBa_K2638003 | BBa_K525998, BBa_K2638001 | T7, RBS, copC |
BBa_K2638004 | BBa_K525998, BBa_K2638002 | T7, RBS, copD |
BBa_K2638016 | BBa_K525998, BBa_K2638000 | T7, RBS, hmtA |
BBa_K2638201 | BBa_K525998, BBa_K2638200 | T7, RBS, oprC |
BBa_K2638005 | BBa_I0500, BBa_B0030, BBa_K2638001 | pBAD/araC, RBS, copC |
BBa_K2638006 | BBa_I0500, BBa_B0030, BBa_K2638002 | pBAD/araC, RBS, copD |
BBa_K2638204 | BBa_I0500, BBa_B0030, BBa_K2638200 | pBAD/araC, RBS, oprC |
Molecular graphics and analyses performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH P41-GM103311.
Butts, C.A., Swift, J., Kang, S., Di Costanzo, L., Christianson, D.W., Saven, J.G., and Dmochowski, I.J. (2008).. Directing Noble Metal Ion Chemistry within a Designed Ferritin Protein † , ‡. Biochemistry 47: 12729–12739.
Castro, L., Blázquez, M.L., Muñoz, J., González, F., and Ballester, A. (2014).. Mechanism and Applications of Metal Nanoparticles Prepared by Bio-Mediated Process. Rev. Adv. Sci. Eng. 3.
Ensign, D., Young, M., and Douglas, T. (2004).. Photocatalytic synthesis of copper colloids from CuII by the ferrihydrite core of ferritin. Inorg. Chem. 43: 3441–3446.
Goujon, M., McWilliam, H., Li, W., Valentin, F., Squizzato, S., Paern, J., and Lopez, R. (2010).. A new bioinformatics analysis tools framework at EMBL-EBI. Nucleic Acids Res. 38: W695-699.
Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., and Ferrin, T.E. (2004).UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem 25: 1605–1612.
Sievers, F., Wilm, A., Dineen, D., Gibson, T.J., Karplus, K., Li, W., Lopez, R., McWilliam, H., Remmert, M., Söding, J., Thompson, J.D., and Higgins, D.G. (2011). Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7: 539.
Ummartyotin, S., Bunnak, N., Juntaro, J., Sain, M., and Manuspiya, H. (2012). . DSynthesis of colloidal silver nanoparticles for printed electronics. /data/revues/16310748/v15i6/S1631074812000549/.
Wang, L., Hu, C., and Shao, L. (2017a).. The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int. J. Nanomedicine 12: 1227–1249.
Wang, Z., Gao, H., Zhang, Y., Liu, G., Niu, G., and Chen, X. (2017b).. Functional ferritin nanoparticles for biomedical applications. Front. Chem. Sci. Eng. 11: 633–646.